New Gene Linked To Congenital Heart Defects
Main Category: Heart DiseaseAlso Included In: Cardiovascular / Cardiology; Genetics
Article Date: 18 Dec 2009 - 0:00 PST
| Patient / Public: | ![]() |
1 (1 votes) |
| Healthcare Prof: | ![]() |
Researchers from the UC San Diego, School of Medicine and colleagues have identified a new gene, ETS-1, that is linked to human congenital heart defects. The landmark study, recently published online in the journal of Human Molecular Genetics, provides important insights into some of the most prevalent forms of congenital heart defects in humans, including ventricular septal defects and potentially hypoplastic left heart syndrome, a uniformly fatal heart abnormality.
"Identification of this gene may have implications for prevention of some of these most common types of congential heart defects," said Paul Grossfeld, MD, associate professor of pediatrics for the UC San Diego School of Medicine and pediatric cardiologist for Rady Children's Hospital-San Diego.
The researchers performed high-resolution chromosomal microarray mapping on human patients identified with the 11q- phenotype. Through a combination of human genetics and functional studies in genetically engineered mice, the researchers were able to pinpoint ETS-1 as a gene for causing at least a subset of the heart defects that occur in 11q- and the general human population.
Characterized by a distinctive facial appearance, Jacobsen syndrome, also known as 11q terminal deletion disorder (11q-), is a rare chromosomal disorder resulting from the partial loss of one copy of human chromosome number 11. It is the loss of genes that leads to multiple clinical challenges associated with 11q- such as congenital heart disease, developmental and behavioral problems, low platelet counts, gastrointestinal, urinary and ophthalmologic abnormalities, failure to thrive and slow growth.
"Nearly 15 years ago, in my first month of pediatric cardiology training at UC San Diego, I came across my first patient with 11q-. To this day, I still care for this child," said Grossfeld. "Since then, I have devoted my career to learning everything about this syndrome and hope that we have now more clearly defined the path to understanding, and perhaps preventing, some forms of congenital heart disease."
This research was funded by grants from the National Institutes of Health, the State of South Dakota, and the Children's Heart Institute Fund from Rady Children's Hospital-San Diego.
Researchers involved in this study include Maoqing Ye, UC San Diego; Chris Coldren, University of Colorado Health Sciences Center; Xingqun Liang, UC San Diego, Teresa Mattina, University of Catania; Elizabeth Goldmuntz, Children's Hospital of Philadelphia; D Woodrow Benson, Cincinnati Children's Hospital; Dunbar Ivy, University of Colorado Health Sciences Center; MB Perryman, University of South Dakota; Lee Ann Garrett-Sinha, SUNY-Buffalo; and Paul Grossfeld, UC San Diego.
Source: University of California, San Diego Health Sciences
Visit our heart disease section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/174399.php>
APA
http://www.medicalnewstoday.com/releases/174399.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





